KJ

Kamalbhai Jagdishbhai Bareiya

Active Director Director DIN 09426406
DIN 09426406 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kamalbhai Jagdishbhai Bareiya

Data last updated:

Kamalbhai Jagdishbhai Bareiya is a Director at Wellwork Pharma Private Limited (since 2021). The company operates in Chemicals.

DIN 09426406
Primary Designation Director
Industry Chemicals
First Appointment 06 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wellwork Pharma Private Limited U24290GJ2021PTC127786
Director06 Dec 20212021Active

Board colleagues of Kamalbhai Jagdishbhai Bareiya

Directorship timeline

Open interactive timeline →
Wellwork Pharma Private Limited
Premium access

Shareholding and investment profile for Kamalbhai Jagdishbhai Bareiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamalbhai Jagdishbhai Bareiya

Kamalbhai Jagdishbhai Bareiya currently holds 1 directorship: Wellwork Pharma Private Limited (Director, since 06 Dec 2021).

Kamalbhai Jagdishbhai Bareiya was first appointed on 06 Dec 2021 as Director at Wellwork Pharma Private Limited.

The current boards of Kamalbhai Jagdishbhai Bareiya's companies include Keyurkumar Chetankumar Dixit (Wellwork Pharma Private Limited), Rajeshbhai Mahendrabhai Dixit (Wellwork Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available